MedTrace Logo

Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine

NCT04981860 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2025-07-10

No results posted yet for this study

Summary

The purpose of this research study is to find out how Avenova (0.01 % hypochlorous acid) works compared to Betadine (Povidone iodide) for reducing bacteria and patient discomfort in the eyes.

Conditions

  • Eye Infections, Bacterial

Interventions

DRUG

Betadine

One drop of 5% Betadine will be administered to the inferior conjunctiva of the eye

DRUG

Avenova

One drop of 0.01% Avenova will be administered to the inferior conjunctiva of the left eye

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Jorge Fortun, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-06
Primary Completion
2025-12-01
Completion
2025-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04981860 on ClinicalTrials.gov